 James Costello
Concepts (405)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 11 | 2023 | 197 | 2.320 |
Why?
| | Gene Expression Profiling | 9 | 2023 | 1537 | 1.440 |
Why?
| | Algorithms | 13 | 2018 | 1500 | 1.320 |
Why?
| | Antineoplastic Agents | 7 | 2020 | 1893 | 1.010 |
Why?
| | Computational Biology | 9 | 2018 | 537 | 0.940 |
Why?
| | Transcriptome | 7 | 2023 | 736 | 0.930 |
Why?
| | Biomarkers, Tumor | 5 | 2022 | 1048 | 0.930 |
Why?
| | Gene Regulatory Networks | 6 | 2023 | 231 | 0.930 |
Why?
| | Cell Line, Tumor | 18 | 2023 | 2751 | 0.870 |
Why?
| | Drug Resistance, Neoplasm | 6 | 2021 | 638 | 0.840 |
Why?
| | Neoplasms | 8 | 2020 | 2118 | 0.840 |
Why?
| | Prostatic Neoplasms | 4 | 2023 | 927 | 0.820 |
Why?
| | Crowdsourcing | 5 | 2023 | 16 | 0.790 |
Why?
| | Computer Simulation | 5 | 2018 | 884 | 0.790 |
Why?
| | Premature Birth | 2 | 2023 | 278 | 0.780 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 28 | 0.740 |
Why?
| | Cisplatin | 2 | 2018 | 263 | 0.700 |
Why?
| | Blood Proteins | 1 | 2021 | 238 | 0.660 |
Why?
| | Pre-Eclampsia | 1 | 2021 | 165 | 0.660 |
Why?
| | Gene Expression Regulation, Neoplastic | 12 | 2023 | 1147 | 0.650 |
Why?
| | MutS Homolog 2 Protein | 1 | 2018 | 12 | 0.650 |
Why?
| | Chromosomes, Human | 1 | 2018 | 39 | 0.630 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 169 | 0.630 |
Why?
| | Gestational Age | 1 | 2021 | 758 | 0.620 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 100 | 0.610 |
Why?
| | Fluorescence | 1 | 2018 | 154 | 0.610 |
Why?
| | Transcription Factors | 4 | 2022 | 1528 | 0.600 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 81 | 0.600 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 29 | 0.590 |
Why?
| | Models, Biological | 4 | 2018 | 1646 | 0.590 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 168 | 0.580 |
Why?
| | Breast Neoplasms | 5 | 2021 | 1872 | 0.570 |
Why?
| | Genetic Loci | 1 | 2018 | 264 | 0.570 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1361 | 0.560 |
Why?
| | Homeodomain Proteins | 5 | 2023 | 465 | 0.550 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 139 | 0.540 |
Why?
| | Genomics | 6 | 2023 | 646 | 0.510 |
Why?
| | Telomerase | 4 | 2020 | 206 | 0.490 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 699 | 0.470 |
Why?
| | MAP Kinase Kinase Kinases | 3 | 2021 | 68 | 0.470 |
Why?
| | Competitive Behavior | 1 | 2013 | 39 | 0.430 |
Why?
| | DNA-Binding Proteins | 6 | 2022 | 1316 | 0.420 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2016 | 746 | 0.410 |
Why?
| | Receptors, Androgen | 3 | 2021 | 132 | 0.400 |
Why?
| | Cooperative Behavior | 2 | 2016 | 390 | 0.390 |
Why?
| | Humans | 55 | 2023 | 115741 | 0.380 |
Why?
| | Carcinoma, Transitional Cell | 3 | 2017 | 54 | 0.380 |
Why?
| | Biomedical Research | 2 | 2016 | 589 | 0.370 |
Why?
| | Rhabdomyosarcoma | 2 | 2022 | 52 | 0.360 |
Why?
| | Drosophila | 3 | 2008 | 132 | 0.360 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2207 | 0.340 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 208 | 0.340 |
Why?
| | Mutation | 7 | 2023 | 3364 | 0.340 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 246 | 0.330 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 102 | 0.320 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2020 | 147 | 0.310 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 190 | 0.300 |
Why?
| | Databases, Genetic | 3 | 2018 | 208 | 0.290 |
Why?
| | DNA Helicases | 2 | 2021 | 133 | 0.290 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 40 | 0.280 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2019 | 157 | 0.270 |
Why?
| | Neoplasm Metastasis | 5 | 2020 | 526 | 0.260 |
Why?
| | Animals | 27 | 2023 | 32104 | 0.260 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 722 | 0.250 |
Why?
| | Promoter Regions, Genetic | 6 | 2021 | 1122 | 0.250 |
Why?
| | Epigenesis, Genetic | 3 | 2020 | 526 | 0.250 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2023 | 178 | 0.250 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 167 | 0.250 |
Why?
| | Meta-Analysis as Topic | 2 | 2023 | 161 | 0.240 |
Why?
| | Proteomics | 3 | 2021 | 859 | 0.220 |
Why?
| | Nuclear Proteins | 2 | 2020 | 594 | 0.220 |
Why?
| | Datasets as Topic | 1 | 2023 | 99 | 0.210 |
Why?
| | Mice | 17 | 2023 | 15052 | 0.210 |
Why?
| | Sarcoma, Ewing | 1 | 2023 | 62 | 0.210 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 6 | 0.200 |
Why?
| | Melanoma | 2 | 2023 | 651 | 0.200 |
Why?
| | Neoplasm Invasiveness | 3 | 2018 | 445 | 0.200 |
Why?
| | ROC Curve | 2 | 2021 | 451 | 0.200 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 5 | 0.200 |
Why?
| | Cell Proliferation | 8 | 2021 | 2194 | 0.190 |
Why?
| | Muscle Development | 1 | 2022 | 93 | 0.190 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 192 | 0.190 |
Why?
| | ADAM10 Protein | 1 | 2021 | 27 | 0.190 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 77 | 0.180 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 28 | 0.180 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 431 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 47 | 0.180 |
Why?
| | Carcinoma, Lobular | 1 | 2021 | 44 | 0.180 |
Why?
| | Gene Ontology | 1 | 2020 | 47 | 0.180 |
Why?
| | Radiosurgery | 1 | 2023 | 298 | 0.180 |
Why?
| | PAX3 Transcription Factor | 1 | 2020 | 11 | 0.180 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 18 | 0.180 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 14 | 0.180 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 863 | 0.180 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 71 | 0.180 |
Why?
| | Wnt Signaling Pathway | 1 | 2022 | 148 | 0.180 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 40 | 0.180 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2020 | 693 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 59 | 0.170 |
Why?
| | Radiation Injuries | 1 | 2021 | 127 | 0.170 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2019 | 31 | 0.170 |
Why?
| | Receptors, Interferon | 1 | 2019 | 47 | 0.170 |
Why?
| | Cell Differentiation | 3 | 2022 | 1700 | 0.170 |
Why?
| | Homologous Recombination | 1 | 2019 | 21 | 0.170 |
Why?
| | Small Molecule Libraries | 1 | 2020 | 81 | 0.170 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 334 | 0.170 |
Why?
| | Discoidin Domain Receptor 2 | 1 | 2019 | 2 | 0.170 |
Why?
| | Prognosis | 7 | 2021 | 3343 | 0.170 |
Why?
| | RNA Interference | 1 | 2021 | 438 | 0.160 |
Why?
| | Female | 19 | 2023 | 60018 | 0.160 |
Why?
| | Trisomy | 1 | 2019 | 68 | 0.160 |
Why?
| | Kynurenine | 1 | 2019 | 80 | 0.160 |
Why?
| | Machine Learning | 2 | 2022 | 321 | 0.160 |
Why?
| | Dasatinib | 1 | 2019 | 46 | 0.160 |
Why?
| | Reproducibility of Results | 2 | 2023 | 2824 | 0.160 |
Why?
| | Microbiota | 2 | 2023 | 653 | 0.160 |
Why?
| | Fibrosis | 1 | 2021 | 457 | 0.160 |
Why?
| | Neoadjuvant Therapy | 1 | 2020 | 301 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 60 | 0.160 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 372 | 0.160 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 171 | 0.160 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 385 | 0.160 |
Why?
| | Chloroquine | 1 | 2018 | 52 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 374 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 114 | 0.150 |
Why?
| | Molecular Conformation | 1 | 2018 | 139 | 0.150 |
Why?
| | Macrolides | 1 | 2018 | 56 | 0.150 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 153 | 0.150 |
Why?
| | Lysosomes | 1 | 2018 | 125 | 0.150 |
Why?
| | Monte Carlo Method | 1 | 2018 | 140 | 0.150 |
Why?
| | Signal Transduction | 6 | 2021 | 4541 | 0.150 |
Why?
| | Histone Code | 1 | 2017 | 28 | 0.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 388 | 0.150 |
Why?
| | Probability | 1 | 2018 | 294 | 0.140 |
Why?
| | Down Syndrome | 2 | 2019 | 336 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 553 | 0.140 |
Why?
| | Adenocarcinoma | 1 | 2023 | 799 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 193 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2019 | 262 | 0.140 |
Why?
| | Cell Death | 1 | 2018 | 326 | 0.140 |
Why?
| | DNA Damage | 1 | 2019 | 357 | 0.140 |
Why?
| | Data Interpretation, Statistical | 2 | 2009 | 324 | 0.140 |
Why?
| | Cadherins | 2 | 2015 | 175 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 139 | 0.140 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.140 |
Why?
| | CD24 Antigen | 1 | 2016 | 20 | 0.140 |
Why?
| | DNA Methylation | 2 | 2017 | 499 | 0.140 |
Why?
| | Nomograms | 1 | 2016 | 42 | 0.140 |
Why?
| | Sulfonamides | 1 | 2020 | 447 | 0.140 |
Why?
| | YY1 Transcription Factor | 1 | 2016 | 27 | 0.140 |
Why?
| | Transcriptional Activation | 1 | 2018 | 340 | 0.130 |
Why?
| | Urologic Neoplasms | 1 | 2016 | 25 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 301 | 0.130 |
Why?
| | Deoxycytidine | 1 | 2017 | 140 | 0.130 |
Why?
| | Organizational Innovation | 2 | 2016 | 132 | 0.130 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 155 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 407 | 0.130 |
Why?
| | Genetic Heterogeneity | 1 | 2015 | 51 | 0.130 |
Why?
| | Bayes Theorem | 3 | 2023 | 334 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 331 | 0.120 |
Why?
| | Survival Rate | 4 | 2021 | 1651 | 0.120 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.120 |
Why?
| | Up-Regulation | 1 | 2018 | 820 | 0.120 |
Why?
| | Immunotherapy | 1 | 2019 | 479 | 0.120 |
Why?
| | Alleles | 1 | 2017 | 794 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 535 | 0.120 |
Why?
| | Telomere Homeostasis | 1 | 2015 | 24 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2021 | 1024 | 0.120 |
Why?
| | Transcription, Genetic | 3 | 2017 | 1310 | 0.120 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2420 | 0.120 |
Why?
| | Histone Demethylases | 1 | 2014 | 28 | 0.120 |
Why?
| | rho GTP-Binding Proteins | 1 | 2014 | 62 | 0.120 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 37 | 0.120 |
Why?
| | Infant, Newborn | 2 | 2023 | 5061 | 0.120 |
Why?
| | Phenotype | 2 | 2020 | 2839 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 630 | 0.120 |
Why?
| | Phylogeny | 3 | 2023 | 805 | 0.120 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2013 | 6 | 0.120 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 137 | 0.120 |
Why?
| | Drug Synergism | 1 | 2014 | 317 | 0.120 |
Why?
| | Anabolic Agents | 1 | 2013 | 11 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1003 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 124 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 520 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2022 | 794 | 0.110 |
Why?
| | Drug Combinations | 1 | 2014 | 289 | 0.110 |
Why?
| | International Cooperation | 1 | 2014 | 174 | 0.110 |
Why?
| | Databases, Protein | 2 | 2014 | 59 | 0.110 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 32 | 0.110 |
Why?
| | Epigenomics | 1 | 2014 | 105 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 2021 | 980 | 0.110 |
Why?
| | Models, Molecular | 1 | 2018 | 1390 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 538 | 0.110 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2021 | 704 | 0.110 |
Why?
| | Biomarkers | 2 | 2021 | 3471 | 0.110 |
Why?
| | Pregnancy | 2 | 2023 | 5553 | 0.110 |
Why?
| | Cluster Analysis | 2 | 2016 | 465 | 0.110 |
Why?
| | Models, Statistical | 1 | 2016 | 606 | 0.110 |
Why?
| | Software | 2 | 2014 | 541 | 0.110 |
Why?
| | Prostate | 1 | 2013 | 157 | 0.100 |
Why?
| | Superoxides | 1 | 2013 | 215 | 0.100 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2012 | 33 | 0.100 |
Why?
| | Integrins | 2 | 2023 | 79 | 0.100 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 89 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 286 | 0.100 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1218 | 0.100 |
Why?
| | Apoptosis | 3 | 2021 | 2377 | 0.100 |
Why?
| | Alternative Splicing | 1 | 2013 | 187 | 0.100 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4773 | 0.100 |
Why?
| | B-Lymphocytes | 2 | 2014 | 773 | 0.100 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 228 | 0.100 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 482 | 0.100 |
Why?
| | Genome, Insect | 2 | 2009 | 22 | 0.100 |
Why?
| | Male | 10 | 2023 | 56050 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 549 | 0.090 |
Why?
| | MCF-7 Cells | 2 | 2021 | 105 | 0.090 |
Why?
| | Testosterone | 1 | 2013 | 337 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 346 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 757 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2129 | 0.090 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2012 | 284 | 0.090 |
Why?
| | Horns | 1 | 2009 | 1 | 0.090 |
Why?
| | Inflammation | 1 | 2020 | 2500 | 0.090 |
Why?
| | Expressed Sequence Tags | 1 | 2009 | 38 | 0.090 |
Why?
| | Pseudogenes | 1 | 2009 | 18 | 0.090 |
Why?
| | Coleoptera | 1 | 2009 | 26 | 0.080 |
Why?
| | Systems Integration | 1 | 2009 | 38 | 0.080 |
Why?
| | Drug Discovery | 2 | 2022 | 124 | 0.080 |
Why?
| | Models, Genetic | 2 | 2009 | 570 | 0.080 |
Why?
| | Stem Cells | 1 | 2013 | 546 | 0.080 |
Why?
| | Genes, Fungal | 1 | 2009 | 49 | 0.080 |
Why?
| | Zebrafish | 2 | 2022 | 412 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 850 | 0.080 |
Why?
| | Genetic Diseases, Inborn | 1 | 2008 | 37 | 0.080 |
Why?
| | Genes, Insect | 1 | 2007 | 19 | 0.080 |
Why?
| | Gene Deletion | 1 | 2009 | 355 | 0.080 |
Why?
| | Mitochondria | 1 | 2013 | 750 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1127 | 0.070 |
Why?
| | Genome, Human | 1 | 2009 | 352 | 0.070 |
Why?
| | BRCA1 Protein | 2 | 2020 | 57 | 0.070 |
Why?
| | Disease | 1 | 2008 | 87 | 0.070 |
Why?
| | Genetics, Population | 1 | 2008 | 192 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2013 | 1093 | 0.070 |
Why?
| | Selection, Genetic | 1 | 2008 | 243 | 0.070 |
Why?
| | Prednisone | 2 | 2017 | 232 | 0.070 |
Why?
| | Chromatin | 2 | 2022 | 429 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4442 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1756 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2651 | 0.060 |
Why?
| | Adult | 3 | 2021 | 30789 | 0.060 |
Why?
| | Base Sequence | 3 | 2017 | 2114 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1485 | 0.060 |
Why?
| | Cell Movement | 2 | 2021 | 867 | 0.060 |
Why?
| | Evolution, Molecular | 1 | 2007 | 440 | 0.060 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 16 | 0.060 |
Why?
| | RNA-Binding Protein EWS | 1 | 2023 | 16 | 0.060 |
Why?
| | Protein Binding | 2 | 2020 | 1917 | 0.060 |
Why?
| | BCG Vaccine | 1 | 2023 | 18 | 0.060 |
Why?
| | Internet | 1 | 2008 | 602 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2016 | 3914 | 0.050 |
Why?
| | Mice, Nude | 2 | 2016 | 639 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 114 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 11 | 0.050 |
Why?
| | Vagina | 1 | 2023 | 148 | 0.050 |
Why?
| | Proteins | 1 | 2008 | 920 | 0.050 |
Why?
| | MyoD Protein | 1 | 2022 | 26 | 0.050 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 16 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 206 | 0.050 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 78 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2022 | 2604 | 0.050 |
Why?
| | Cell Lineage | 2 | 2013 | 310 | 0.050 |
Why?
| | Aged | 4 | 2023 | 19294 | 0.050 |
Why?
| | Chondrogenesis | 1 | 2022 | 79 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2022 | 91 | 0.050 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 40 | 0.050 |
Why?
| | Skull | 1 | 2022 | 117 | 0.050 |
Why?
| | Ephrin-B2 | 1 | 2021 | 35 | 0.050 |
Why?
| | Wnt Proteins | 1 | 2022 | 135 | 0.050 |
Why?
| | Neural Crest | 1 | 2022 | 117 | 0.050 |
Why?
| | Breast | 1 | 2021 | 138 | 0.050 |
Why?
| | Nitriles | 1 | 2021 | 152 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 168 | 0.040 |
Why?
| | Cartilage | 1 | 2022 | 182 | 0.040 |
Why?
| | Tamoxifen | 1 | 2021 | 192 | 0.040 |
Why?
| | beta Catenin | 1 | 2022 | 220 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 129 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 19 | 0.040 |
Why?
| | Chondrocytes | 1 | 2022 | 199 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 44 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 165 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1660 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 118 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 150 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 157 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2018 | 2 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 546 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 321 | 0.040 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 37 | 0.040 |
Why?
| | 5-Methylcytosine | 1 | 2017 | 16 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 391 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 816 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 118 | 0.040 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 790 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 560 | 0.040 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2017 | 59 | 0.040 |
Why?
| | Co-Repressor Proteins | 1 | 2016 | 13 | 0.030 |
Why?
| | Taxoids | 1 | 2016 | 94 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2016 | 43 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2016 | 95 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1168 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 1856 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 154 | 0.030 |
Why?
| | Heterografts | 1 | 2016 | 119 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 242 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 156 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 209 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 302 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 1919 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 732 | 0.030 |
Why?
| | Exome | 1 | 2016 | 202 | 0.030 |
Why?
| | rhoC GTP-Binding Protein | 1 | 2014 | 5 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2016 | 185 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2016 | 489 | 0.030 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.030 |
Why?
| | Urothelium | 1 | 2015 | 33 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 965 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 538 | 0.030 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2014 | 57 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1219 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1436 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 235 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 332 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2014 | 29 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2014 | 15 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 244 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2790 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2353 | 0.030 |
Why?
| | Eflornithine | 1 | 2013 | 7 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 2013 | 12 | 0.030 |
Why?
| | Point Mutation | 1 | 2015 | 217 | 0.030 |
Why?
| | Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 198 | 0.030 |
Why?
| | Aminoglycosides | 1 | 2013 | 13 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 822 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1153 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 362 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1139 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 277 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1001 | 0.030 |
Why?
| | beta-Lactams | 1 | 2013 | 27 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 941 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2017 | 9162 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 443 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2016 | 1178 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 793 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 434 | 0.030 |
Why?
| | Doxycycline | 1 | 2012 | 56 | 0.030 |
Why?
| | Genes, ras | 1 | 2012 | 91 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2013 | 239 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 84 | 0.030 |
Why?
| | Antigens, CD | 1 | 2014 | 442 | 0.030 |
Why?
| | Quinolones | 1 | 2013 | 97 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 10518 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 1853 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 287 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 778 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 369 | 0.020 |
Why?
| | Middle Aged | 3 | 2017 | 27069 | 0.020 |
Why?
| | Benzimidazoles | 1 | 2012 | 137 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2013 | 431 | 0.020 |
Why?
| | DNA | 1 | 2017 | 1356 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1243 | 0.020 |
Why?
| | Pupa | 1 | 2009 | 10 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 867 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 117 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1024 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 17922 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1642 | 0.020 |
Why?
| | Larva | 1 | 2009 | 193 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 385 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 1970 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 730 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2423 | 0.020 |
Why?
| | Synteny | 1 | 2007 | 17 | 0.020 |
Why?
| | Gene Order | 1 | 2007 | 24 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 8702 | 0.020 |
Why?
| | Genome, Mitochondrial | 1 | 2007 | 27 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2574 | 0.020 |
Why?
| | Codon | 1 | 2007 | 86 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6171 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 100 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 327 | 0.020 |
Why?
| | Immunity | 1 | 2007 | 124 | 0.020 |
Why?
| | Multigene Family | 1 | 2007 | 193 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2008 | 189 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6423 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2007 | 113 | 0.020 |
Why?
| | Reproduction | 1 | 2007 | 180 | 0.020 |
Why?
| | Drosophila Proteins | 1 | 2007 | 159 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1447 | 0.010 |
Why?
| | Child | 1 | 2023 | 18503 | 0.010 |
Why?
| | RNA | 1 | 2008 | 820 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 3580 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|